Genomics platform company enabling cellular resolution in clinical diagnostics.
Sampling Human has raised $2.0M in total funding. The most recent round was Seed. The last funding was announced in April 2022.
Sampling Human's investors include Longevitytech.fund, i&i Prague, i&i Biotech Fund, Formic Ventures, bpd partners.
Sampling Human is headquartered in Berkeley, United States.
Genomics platform company enabling cellular resolution in clinical diagnostics.
Sampling Human is at the Seed stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Sampling Human — Funding & Investors." VCBacked, April 12, 2022, https://www.vcbacked.co/company/sampling-human. Accessed October 1, 2026.
VCBacked. (2022). Sampling Human — Funding & Investors. Retrieved October 1, 2026, from https://www.vcbacked.co/company/sampling-human
{{cite web |title=Sampling Human — Funding & Investors |url=https://www.vcbacked.co/company/sampling-human |website=VCBacked |access-date=October 1, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated